CYCN - Korsana Biosciences

CYCN is a company, not a closed-end fund. We still track it - notices about it are below - but most of this site is about funds.

Is anyone targeting this fund?

Yes - 3 large investors hold stakes in this company, and 2 of them are pushing for changes.

What this means for you

Fairmount Funds Management LLC and Venrock Healthcare Capital Partners III, L.P. have told the regulator it may push for changes at this company. That usually means asking for a seat on the board, a sale of the company, or a change in how it is run.

Nothing is required of you now.

Large investors can also sell down and walk away. We show every notice they file, the day it is filed.

Email me if this changes

What happened, and when

  1. Sept 16, 2026

    Wellington Biomedical Innovation Master Investors (Cayman) II, L.P. now owns 6.1%, as a passive investor.

    Original document →
  2. Sept 15, 2026

    Venrock Healthcare Capital Partners III, L.P. now owns 9.9%. It has said it may push for changes.

    Original document →
  3. Sept 11, 2026

    Fairmount Funds Management LLC now owns 20%. It has said it may push for changes.

    Original document →
Details: all notices, events and fund facts
Notices from large investors about CYCN
DateInvestorStakeType of notice
Sept 16, 2026 Wellington Biomedical Innovation Master Investors (Cayman) II, L.P. 6.1% Passive investor
Sept 15, 2026 Venrock Healthcare Capital Partners III, L.P. 9.9% May push for changes
Sept 11, 2026 Fairmount Funds Management LLC 20% May push for changes

No announcements from the fund on file.

Run by
not filed yet
Fund family
not filed yet
Exchange
Nasdaq

See this fund's page at the SEC →

Download this fund's history (CSV)

Email me when something new is filed for CYCN

Free. One email per notice or announcement, usually within a day. No password.